Stocks
USANA Health Sciences Financial Statements (USNA) |
||||||||||
| USANA Health Sciencessmart-lab.ru | % | 2023Q3 | 2023Q4 | 2023Q4 | 2024Q1 | 2024Q1 | LTM ? | |||
|---|---|---|---|---|---|---|---|---|---|---|
| Report date | 07.11.2023 | 31.12.2023 | 27.02.2024 | 30.04.2024 | 07.05.2024 | 07.05.2024 | ||||
| Currency | USD | USD | USD | USD | USD | USD | ||||
| Financial report URL | ||||||||||
| Revenue, bln rub | ? | 213.4 | 221.1 | 221.1 | 227.8 | 227.8 | 897.8 | |||
| Operating Income, bln rub | 17.6 | 24.2 | 24.2 | 24.7 | 24.7 | 97.8 | ||||
| EBITDA, bln rub | ? | 17.6 | 24.2 | 24.2 | 27.8 | 32.2 | 108.5 | |||
| Net profit, bln rub | ? | 11.3 | 16.8 | 16.8 | 16.5 | 16.5 | 66.6 | |||
| OCF, bln rub | ? | 22.2 | 0.000 | 26.0 | 0.000 | 17.7 | 43.7 | |||
| CAPEX, bln rub | ? | 1.45 | 0.000 | 7.32 | 0.000 | 3.20 | 10.5 | |||
| FCF, bln rub | ? | 20.8 | 0.000 | 18.7 | 0.000 | 14.5 | 33.2 | |||
| Dividend payout, bln rub | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | ||||
| Ordinary share dividend yield, % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | ||||
| Dividend payout ratio, % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0 | ||||
| OPEX, bln rub | 153.2 | 154.5 | 154.5 | 160.1 | 160.1 | 629.2 | ||||
| Cost of production, bln rub | 42.5 | 42.3 | 42.3 | 43.1 | 43.1 | 170.8 | ||||
| R&D, bln rub | 0.000 | 0.000 | 11.4 | 0.000 | 0.000 | 11.4 | ||||
| Interest expenses, bln rub | 0.043 | 0.000 | 0.145 | 0.052 | 0.052 | 0.249 | ||||
| Assets, bln rub | 601.1 | 632.8 | 632.8 | 629.3 | 629.3 | 629.3 | ||||
| Net Assets, bln rub | ? | 470.4 | 497.2 | 497.2 | 500.0 | 500.0 | 500.0 | |||
| Debt, bln rub | 2.58 | 0.786 | 13.2 | 1.32 | 1.32 | 1.32 | ||||
| Cash, bln rub | 307.1 | 330.4 | 330.4 | 328.3 | 328.3 | 328.3 | ||||
| Net debt, bln rub | -304.5 | -329.6 | -317.2 | -327.0 | -327.0 | -327.0 | ||||
| Ordinary share price, rub | 58.6 | 53.6 | 53.6 | 48.5 | 48.5 | 45.1 | ||||
| Number of ordinary shares, mln | 19.2 | 19.3 | 19.1 | 19.2 | 19.2 | 19.2 | ||||
| Market cap, bln rub | 1 128 | 1 032 | 1 025 | 930 | 930 | 864 | ||||
| EV, bln rub | ? | 823 | 702 | 708 | 603 | 603 | 537 | |||
| Book value, bln rub | 424 | 480 | 450 | 454 | 454 | 454 | ||||
| EPS, rub | ? | 0.59 | 0.87 | 0.88 | 0.86 | 0.86 | 3.47 | |||
| FCF/share, rub | 1.08 | 0.00 | 0.98 | 0.00 | 0.76 | 1.73 | ||||
| BV/share, rub | 22.0 | 24.9 | 23.5 | 23.7 | 23.7 | 23.7 | ||||
| EBITDA margin, % | ? | 8.25% | 11.0% | 11.0% | 12.2% | 14.2% | 12.1% | |||
| Net margin, % | ? | 5.32% | 7.58% | 7.58% | 7.26% | 7.26% | 7.42% | |||
| FCF yield, % | ? | 3.32% | 2.59% | 4.43% | 4.25% | 5.80% | 3.84% | |||
| ROE, % | ? | 13.7% | 12.5% | 12.5% | 12.3% | 12.3% | 13.3% | |||
| ROA, % | ? | 10.7% | 9.83% | 9.83% | 9.76% | 9.76% | 10.6% | |||
| P/E | ? | 17.5 | 16.6 | 16.5 | 15.1 | 15.1 | 13.0 | |||
| P/FCF | 30.1 | 38.6 | 22.6 | 23.6 | 17.2 | 26.0 | ||||
| P/S | ? | 1.20 | 1.15 | 1.15 | 1.05 | 1.05 | 0.96 | |||
| P/BV | ? | 2.66 | 2.15 | 2.28 | 2.05 | 2.05 | 1.90 | |||
| EV/EBITDA | ? | 8.83 | 7.77 | 7.83 | 6.42 | 6.13 | 4.95 | |||
| Debt/EBITDA | -3.27 | -3.64 | -3.51 | -3.48 | -3.33 | -3.01 | ||||
| R&D/CAPEX, % | 0.00% | 156.3% | 0.00% | 108.8% | ||||||
| CAPEX/Revenue, % | 0.68% | 0.00% | 3.31% | 0.00% | 1.41% | 1.17% | ||||
| USANA Health Sciences shareholders | ||||||||||
